Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Almac Launches Next Gen Sequencing Service | Contract Pharma

What are you searching for?

Sign in
Breaking News

Almac Launches Next Gen Sequencing Service

Expands personalized medicine offering

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Almac has launched a Next Generation Sequencing (NGS) service, expanding its portfolio of services for the development of personalized medicine. This service provides support for the development of molecular tests for trial enrichment and companion diagnostic development, with a focus on targeted re-sequencing. The NGS platform expands Almac’s current services using microarray, qPCR and IHC.
 
Professor Paul Harkin, president and managing director of Almac’s Diagnostics business unit and Professor of Molecular Oncology at Queens University Belfast, said, “There are only a limited number of platforms that are truly amenable to diagnostic delivery. The NGS field has now moved to a point where it is a viable delivery platform and as such is a logical addition to our suite of services. We have already begun the process of developing CLIA-based assays for important mutations involved in drug response.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics